Back

Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Mitral Valve Interventions Mitral valve interventions ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Oliver Doerr

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt am Main (Germany)

11 More presentations in this session

Presentation thumbnail
Associate Professor M. Spieker (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Doctor B. Goebel (Bad Berka, DE)
Abstract
Presentation thumbnail
Doctor N. Ruozi (Reggio Nell'Emilia, IT)
Abstract Slides
Presentation thumbnail
Doctor K. Hellhammer (Duesseldorf, DE)
Abstract
Presentation thumbnail
Doctor D. Kalbacher (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Mitral Valve Interventions

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Value of combined plasma NGAL, Cystatin C and NT-proBNP in the diagnosis of cardiorenal syndrome type 1
29 June 2021
thumbnail
Congress Presentation
Trans-catheter mitral valve repair in the elderly and very elderly patients with focus on postprocedural safety and 1year-effectiveness
28 August 2022
thumbnail
Congress Presentation
Every third patient with advanced renal failure dies within one year following non st-segment elevation myocardial infarction treated with percutaneous coronary intervention
25 August 2023
thumbnail
Congress Presentation
The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources